Signet Healthcare completed the investment in NorthX Biologics.

Signet Healthcare, a healthcare private equity firm, completed the investment in NorthX Biologics, a Nordic biopharmaceutical contract, development and manufacturing organization. Financial terms were not disclosed. “We are delighted to welcome Signet Healthcare Partners as a shareholder. With their significant experience in pharma services, they are an excellent complement to NorthX Biologics and are well positioned to support our journey,” Janet Hoogstraate, NorthX Biologics CEO.